Claire White, BSN, RN, CPHONThe Children's Hospital of Philadelphia, Philadelphia, PA
Navigation’s Impact on Clinical Trial Participation in Cancer Research: Barriers, Evidence, and Strategies
Claire White, BSN, RN, CPHON, Laura Hynes, MA, BSN, RN, Lucy J. Gansauer, MSN, RN, OCN, CCRP, Mary Van Cleave, BSN, RN, OCN, Lavinia Dobrea, RN, MS, OCN, Amy Meleason, BSN, RN, OCN, Daniel McGough, BS, CCRP
August 5, 2019 | August 2019 Vol 10, No 8
What you need to know about discussing clinical trials with your patients.
Creating a Pediatric Cancer Immunotherapy Nurse Navigator Role: Developing Complex Care Coordination Processes
November 14, 2017 | November 2017 Vol 8, No 11
Accessing chimeric antigen receptor (CAR) T-cell clinical trials for relapsed and refractory B-cell acute lymphoblastic leukemia (ALL) is challenging for pediatric patients who have experienced a relapse of B-cell ALL or have been refractory to standard therapy.
Last modified: March 5, 2019